Business Segments · Interest Expense
Reportable Segment — Interest Expense
Insmed Reportable Segment — Interest Expense decreased by 81.1% to $20.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 193.1%, from -$21.57M to $20.08M. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Interest Expense shows an upward trend with a 46.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toInterest Expense
How to read this metric
A decrease indicates lower debt levels or improved refinancing terms, reducing financial risk.
Detailed definition
This represents the cost of borrowing funds, including interest on debt instruments and credit facilities. It is a measu...
Peer comparison
Standard metric for evaluating the debt burden of a company.
Metric ID:
insm_segment_reportable_segment_interest_expenseHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.61M | $6.61M | $6.61M | $6.61M | $20.42M | $20.42M | $20.42M | $20.42M | -$21.04M | -$21.27M | $21.05M | $106.17M | -$21.57M | -$21.25M | $20.38M | $106.23M | $20.08M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +208.9% | +0.0% | +0.0% | +0.0% | -203.0% | -1.1% | +199.0% | +404.3% | -120.3% | +1.5% | +195.9% | +421.2% | -81.1% |
| YoY Change | — | — | — | — | +208.9% | +208.9% | +208.9% | +208.9% | -203.0% | -204.1% | +3.1% | +419.8% | -2.5% | +0.1% | -3.2% | +0.1% | +193.1% |
Range-$21.57M – $106.23M
CAGR+32.0%
Avg YoY Growth+79.9%
Median YoY Growth+3.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Insmed's reportable segment — interest expense?
- Insmed (INSM) reported reportable segment — interest expense of $20.08M in Q1 2026.
- How has Insmed's reportable segment — interest expense changed year-over-year?
- Insmed's reportable segment — interest expense increased by 193.1% year-over-year, from -$21.57M to $20.08M.
- What is the long-term trend for Insmed's reportable segment — interest expense?
- Over 3 years (2022 to 2025), Insmed's reportable segment — interest expense has grown at a 46.9% compound annual growth rate (CAGR), from $26.45M to $83.80M.
- What does reportable segment — interest expense mean?
- The total cost of interest paid on the company's outstanding debt.